Drugs tested in silico.
Before they ever touch a body.
First an animal. Then a volunteer. Then you.
We had no other way.
To know what a drug does in a body, you had to dose a body. A molecule binds a receptor. The receptor moves a cell. The cell shifts an organ. No code could trace that chain end to end. The body was the only instrument we had.
We predict what a drug will do. Before it touches a body. Our model learns from real tissue.
Every drug acts on a tissue.
Discovery scaled.
Testing did not.
$3.7B raised to design what no lab can test.
Their compounds need our testbed.
For seventy years, animal testing was the law.
In thirty-six months that changed.
- Dec 2022RepealedFDA Modernization Act 2.0
- Apr 2025ReplacedFDA roadmap
- 2026RequiredCDER draft guidance
The regulator went from forbidding what we sell to requiring it.
The foundations of post-experimental medicine.
No more failed drugs. No more animal testing. No more lost decades.
Patent first. Then test.
The patent clock starts before testing begins. Every month we remove is a month the drug sells under monopoly instead of after.
Then, the trial.
Phase I to III, simulated. Before the first volunteer. The same pattern — predict the outcome, then test only what survives.
Supported by MD Fellowship · Teleport · NVIDIA Inception